AAS
VKTX icon

Ameritas Advisory Services’s Viking Therapeutics VKTX Stock Holding History

Ameritas Advisory Services’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.4K Buy
+831
New +$26.8K ﹤0.01% 1317
2025
Q4 		– Sell
-78
Closed -$2.05K – 2079
2025
Q3 		$2.05K Sell
78
-2
-3% -$60 ﹤0.01% 1986
2025
Q2 		$2.12K Buy
+80
New +$2.11K ﹤0.01% 2466
2024
Q3 		– Sell
-7,100
Closed -$376K – 943
2024
Q2 		$376K Sell
7,100
-35
-0.5% -$2.29K 0.01% 663
2024
Q1 		$541K Buy
+7,135
New +$317K 0.02% 538

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Ameritas Advisory Services's VKTX Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 831 shares worth $32.4K. The stake represents ﹤0.01% of the portfolio and ranks #1317 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in VKTX as recently as Q3 2025.

Ameritas Advisory Services first reported a position in VKTX in Q1 2024 and has held it in 5 quarters since. The position peaked at $541K in Q1 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Ameritas Advisory Services held 831 shares of Viking Therapeutics worth $32.4K as of Q2 2026.
  • Viking Therapeutics was a new Ameritas Advisory Services position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1317 holding.
  • Ameritas Advisory Services first reported a position in Viking Therapeutics in Q1 2024 and has held it in 5 quarters since.
  • Ameritas Advisory Services's Viking Therapeutics position peaked at $541K in Q1 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.